Log In
BCIQ
Print this Print this
 

Combivir, lamivudine/zidovudine

Also known as: AZT/3TC

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionCombination of two nucleoside analog reverse transcriptase inhibitor
Molecular Target Viral DNA polymerase
Mechanism of ActionViral polymerase inhibitor
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection
Regulatory Designation
PartnerPfizer Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/20/2009

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today